Kerr JS - Search Results

1

Antiangiogenesis and anticancer efficacy of TA138, a novel alphavbeta3 antagonist.

Mousa SA, Mohamed S, Wexler EJ, Kerr JS. Mousa SA, et al. Among authors: kerr js. Anticancer Res. 2005 Jan-Feb;25(1A):197-206. Anticancer Res. 2005. PMID: 15816539 Free article.

2

The alpha v integrin antagonists as novel anticancer agents: an update.

Kerr JS, Slee AM, Mousa SA. Kerr JS, et al. Expert Opin Investig Drugs. 2002 Dec;11(12):1765-74. doi: 10.1517/13543784.11.12.1765. Expert Opin Investig Drugs. 2002. PMID: 12457436 Review.

3

Novel small molecule alpha v integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitors.

Kerr JS, Wexler RS, Mousa SA, Robinson CS, Wexler EJ, Mohamed S, Voss ME, Devenny JJ, Czerniak PM, Gudzelak A Jr, Slee AM. Kerr JS, et al. Anticancer Res. 1999 Mar-Apr;19(2A):959-68. Anticancer Res. 1999. PMID: 10368639

4

Antiangiogenesis efficacy of nitric oxide donors.

Powell JA, Mohamed SN, Kerr JS, Mousa SA. Powell JA, et al. Among authors: kerr js. J Cell Biochem. 2000 Sep 18;80(1):104-14. doi: 10.1002/1097-4644(20010101)80:1<104::aid-jcb90>3.0.co;2-k. J Cell Biochem. 2000. PMID: 11029757

5

Tumor biology: use of tiled images in conjunction with measurements of cellular proliferation and death in response to drug treatments.

Wexler EJ, Gravallese EM, Czerniak PM, Devenny JJ, Longtine J, Wong MK, Slee AM, Kerr JS. Wexler EJ, et al. Among authors: kerr js. Clin Cancer Res. 2000 Aug;6(8):3361-70. Clin Cancer Res. 2000. PMID: 10955824

6

Small molecule alpha(v) integrin antagonists: novel anticancer agents.

Kerr JS, Slee AM, Mousa SA. Kerr JS, et al. Expert Opin Investig Drugs. 2000 Jun;9(6):1271-9. doi: 10.1517/13543784.9.6.1271. Expert Opin Investig Drugs. 2000. PMID: 11060742 Review.

7

Antisense oligonucleotides selectively regulate aspartyl beta-hydroxylase and its truncated protein isoform in vitro but distribute poorly into A549 tumors in vivo.

Ho SP, Scully MS, Krauthauser CM, Wexler EJ, Stow MD, Dinchuk JE, Kerr JS, Friedman PA. Ho SP, et al. Among authors: kerr js. J Pharmacol Exp Ther. 2002 Aug;302(2):795-803. doi: 10.1124/jpet.302.2.795. J Pharmacol Exp Ther. 2002. PMID: 12130746

8

Alpha(v)beta(3) integrin in angiogenesis and restenosis.

Kerr JS, Mousa SA, Slee AM. Kerr JS, et al. Drug News Perspect. 2001 Apr;14(3):143-50. Drug News Perspect. 2001. PMID: 12819820

9

An objective procedure for ischemic area evaluation of the stroke intraluminal thread model in the mouse and rat.

Wexler EJ, Peters EE, Gonzales A, Gonzales ML, Slee AM, Kerr JS. Wexler EJ, et al. Among authors: kerr js. J Neurosci Methods. 2002 Jan 15;113(1):51-8. doi: 10.1016/s0165-0270(01)00476-9. J Neurosci Methods. 2002. PMID: 11741721

10

Involvement of endothelial PECAM-1/CD31 in angiogenesis.

DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, Kerr JS, Garlanda C, Merwin JR, Madri JA, Albelda SM. DeLisser HM, et al. Among authors: kerr js. Am J Pathol. 1997 Sep;151(3):671-7. Am J Pathol. 1997. PMID: 9284815 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters